Business
Platinum leads immuno-oncology company HaemaLogiX’s $10m round – The Australian Financial Review
Blood cancer immuno-oncology comapny HaemaLogiX is the latest to raise capital, bringing on Platinum Asset Management as its…
KappaMab is designed to enable the immune system to recognise the abnormal cancer cells and kill them.
Platinum Asset Management fund manager Bianca Ogden said the fund had been following the progress of HaemaLogiX and believed now was the right time to…
Continue Reading
-
General21 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
Noosa News23 hours agoRaising your voice | Noosa Today
-
Noosa News20 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General10 hours agoWallaroos fall to Black Ferns 37-12 in Wellington Test